These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion. Russell A; Statter M; Shina A; Perlman M Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813 [No Abstract] [Full Text] [Related]
3. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)]. Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693 [No Abstract] [Full Text] [Related]
4. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine). Mogoş T; Cheţa CP; Mincu IT Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313 [TBL] [Abstract][Full Text] [Related]
5. [Biochemical-genetic studies in maple syrup disease]. Goedde HW; Blume KG Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703 [No Abstract] [Full Text] [Related]
6. [A case of maple syrup disease. Clinical and electroencephalographic observations with dietetic experiment. Critical review of literature]. Grossi-Bianchi ML; Gatti R; Marchi AG Minerva Pediatr; 1967 Aug; 19(33):1552-65. PubMed ID: 4889027 [No Abstract] [Full Text] [Related]
7. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children]. Kowalik A; Narojek L; Sykut-Cegielska J Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097 [TBL] [Abstract][Full Text] [Related]
8. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease. Kindt E; Halvorsen S Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930 [TBL] [Abstract][Full Text] [Related]
9. M aple syrup urine disease. A review with a report of an additional case. Schwartz JF; Kolendrianos ET Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351 [No Abstract] [Full Text] [Related]
10. [Clinico-metabolic aspects of maple syrup urine disease and manifestation of some new trophometabolic relationships]. Popa W; Apostolescu I; Popescu G Pediatria (Bucur); 1970; 19(1):51-6. PubMed ID: 5419930 [No Abstract] [Full Text] [Related]
17. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts. Skaper SD; Molden DP; Seegmiller JE Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377 [TBL] [Abstract][Full Text] [Related]
18. The therapy of maple syrup urine disease. Snyderman SE Am J Dis Child; 1967 Jan; 113(1):68-73. PubMed ID: 6015908 [No Abstract] [Full Text] [Related]
19. Enzyme activity in classical and variant forms of maple syrup urine disease. Dancis J; Hutzler J; Snyderman SE; Cox RP J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489 [No Abstract] [Full Text] [Related]
20. [Maple syrup urine disease with an intermittent relatively benign course]. Müller H; Bickel H; Feist D; Lutz P Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339 [No Abstract] [Full Text] [Related] [Next] [New Search]